{"id":"https://openalex.org/W635527883","doi":null,"title":"The world pharmaceutical industry","display_name":"The world pharmaceutical industry","publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W635527883","mag":"635527883"},"language":"en","primary_location":{"id":"pmh:oai:aleph.bib-bvb.de:BVB01-005090109","doi":null,"is_oa":false,"landing_page_url":"http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005090109&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113580379","display_name":"J. H. Taggart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. H. Taggart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5113580379"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.1635,"has_fulltext":false,"cited_by_count":101,"citation_normalized_percentile":{"value":0.98151565,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13151","display_name":"Business Strategies and Innovation","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmaceutical-business-strategy","display_name":"pharmaceutical business strategy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7149999737739563},{"id":"https://openalex.org/keywords/market-competition","display_name":"market competition","score":0.5049999952316284},{"id":"https://openalex.org/keywords/competitive-advantage","display_name":"competitive advantage","score":0.6660000085830688},{"id":"https://openalex.org/keywords/innovation-management","display_name":"innovation management","score":0.5920000076293945},{"id":"https://openalex.org/keywords/pharmaceutical-marketing","display_name":"pharmaceutical marketing","score":0.5120000243186951},{"id":"https://openalex.org/keywords/global-pharmaceutical-market","display_name":"global pharmaceutical market","score":0.5899999737739563},{"id":"https://openalex.org/keywords/european-pharmaceutical-market","display_name":"European pharmaceutical market","score":0.6980000138282776},{"id":"https://openalex.org/keywords/glaxo","display_name":"Glaxo","score":0.8519999980926514},{"id":"https://openalex.org/keywords/upjohn","display_name":"Upjohn","score":0.9700000286102295},{"id":"https://openalex.org/keywords/genentech","display_name":"Genentech","score":0.9990000128746033},{"id":"https://openalex.org/keywords/roche","display_name":"Roche","score":0.9819999933242798}],"concepts":[{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6121174097061157},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.545490026473999},{"id":"https://openalex.org/C2780215875","wikidata":"https://www.wikidata.org/wiki/Q4906718","display_name":"Big business","level":2,"score":0.46360719203948975},{"id":"https://openalex.org/C54750564","wikidata":"https://www.wikidata.org/wiki/Q26643","display_name":"Commerce","level":1,"score":0.4236694574356079},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.361810564994812},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.3610116243362427},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.21849703788757324},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.17133048176765442},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.12100759148597717},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:aleph.bib-bvb.de:BVB01-005090109","doi":null,"is_oa":false,"landing_page_url":"http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005090109&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"},{"id":"mag:635527883","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA19322731","pdf_url":null,"source":{"id":"https://openalex.org/S4306463855","display_name":"Routledge eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319847","host_organization_name":"Routledge","host_organization_lineage":["https://openalex.org/P4310319847","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Routledge","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Routledge eBooks","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9","score":0.6399999856948853}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3128006515","https://openalex.org/W1484600428","https://openalex.org/W2494880000","https://openalex.org/W1588263418","https://openalex.org/W2263883986","https://openalex.org/W2465652233","https://openalex.org/W2523287803","https://openalex.org/W376169742","https://openalex.org/W2610740165","https://openalex.org/W49542900"],"abstract_inverted_index":{"Pharmaceuticals":[0],"are":[1,50,60,78,94],"big":[2],"business":[3,119],"as":[4],"companies":[5,141],"invest":[6],"huge":[7,89],"amounts":[8],"of":[9,20,111,153,167],"money":[10],"in":[11,46,96,121,132],"research":[12],"and":[13,82,87,101,146,149,157,170],"compete":[14],"vigorously":[15],"for":[16],"markets.":[17],"The":[18,43,62],"survival":[19],"a":[21,26,56,103],"company":[22],"can":[23,85],"rest":[24],"on":[25,40,74],"single,":[27],"global":[28],"block-busting":[29],"drug":[30,57],"while":[31,52],"scandals":[32],"over":[33],"drugs":[34],"like":[35,142,155],"Myodil":[36],"put":[37],"severe":[38],"pressure":[39],"regulatory":[41],"bodies.":[42],"risks":[44],"involved":[45],"developing":[47,97],"new":[48],"products":[49,77,154],"numerous,":[51],"the":[53,66,68,109,112,118,129,136,151,165,168],"returns,":[54],"if":[55],"is":[58],"successful,":[59],"enormous.":[61],"author":[63],"looks":[64,116,163],"at":[65,117,135,164],"way":[67],"industry":[69,169],"works":[70],"with":[71],"particular":[72],"emphasis":[73],"strategy.":[75],"If":[76],"not":[79],"accurately":[80],"targeted":[81],"marketed,":[83],"they":[84],"fail":[86],"incur":[88],"losses.":[90],"Rigorous":[91],"management":[92],"strategies":[93,137],"essential":[95],"continuous":[98],"innovation":[99],"processes":[100],"sustain":[102],"company's":[104],"competitive":[105],"advantage.":[106],"After":[107],"analyzing":[108],"framework":[110],"industry,":[113],"James":[114],"Taggart":[115],"environment":[120],"four":[122],"key":[123],"world":[124],"markets,":[125],"taking":[126],"into":[127],"account":[128],"latest":[130],"developments":[131],"Europe.":[133],"Looking":[134],"adopted":[138],"by":[139],"world-dominating":[140],"Glaxo,":[143],"Upjohn,":[144],"Genentech":[145],"La":[147],"Roche,":[148],"discussing":[150],"importance":[152],"fragrances":[156],"vitamins":[158],"alongside":[159],"drugs,":[160],"this":[161],"book":[162],"future":[166],"its":[171],"giants.":[172]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}